Carmen Tur
Overview
Explore the profile of Carmen Tur including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
2264
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vaccination in multiple sclerosis: Tackling challenges and paving the way for effective immunization
Carvajal R, Tur C, Borras-Bermejo B, Saylor D, Montalban X, Tintore M, et al.
Mult Scler
. 2025 Mar;
:13524585251318513.
PMID: 40071952
Background: Vaccination in patients with multiple sclerosis (PwMS) presents unique challenges. Disease-modifying therapies (DMTs) can increase infectious risks, though these are largely preventable through immunizations. However, DMTs can also reduce...
2.
Solanky B, Prados F, Tur C, Grussu F, Al-Ahmad S, Yang X, et al.
Sci Rep
. 2025 Feb;
15(1):7014.
PMID: 40016502
Spinal cord injury causes a cascade of physiological responses, which may trigger a subsequent neurotoxic increase in intracellular sodium. This can lead to neurodegeneration, both at and beyond the site...
3.
Marrodan M, Sao Aviles A, Rio J, Cobo-Calvo A, Fernandez V, Pappolla A, et al.
Mult Scler
. 2025 Feb;
:13524585251316471.
PMID: 39925147
Background: Predicting treatment response and disease progression in multiple sclerosis (MS) is challenging. Treatment Response Scoring Systems (TRSS) are potentially useful, but their utility in patients receiving high-efficacy therapies and...
4.
Vilaseca A, Tintore M, Carbonell-Mirabent P, Rodriguez-Barranco M, Arevalo M, Arino H, et al.
Mult Scler
. 2025 Feb;
:13524585251314749.
PMID: 39907218
Background: It is essential to exclude alternative diagnoses to diagnose multiple sclerosis (MS). However, detailed descriptions of alternative diagnoses in patients with suspected MS presenting with clinically isolated syndrome (CIS)...
5.
Cobo-Calvo A, Carbonell-Mirabent P, Tur C, Otero-Romero S, Carvajal R, Arrambide G, et al.
Neurology
. 2025 Feb;
104(4):e210305.
PMID: 39903901
Background And Objectives: Emerging concepts in the early detection of multiple sclerosis (MS) progression reveal that disability accumulation can start early in the disease course. Aging in MS is increasingly...
6.
Comabella M, Pappolla A, Monreal E, Fissolo N, Sao-Aviles A, Arrambide G, et al.
Neurol Neuroimmunol Neuroinflamm
. 2025 Jan;
12(2):e200370.
PMID: 39879564
Background And Objectives: Invasive procedures may delay the diagnostic process in multiple sclerosis (MS). We investigated the added value of serum neurofilament light chain (sNfL), glial fibrillary acidic protein (sGFAP),...
7.
Carvajal R, Guananga-Alvarez D, Tur C, Esperalba J, Rodriguez-Barranco M, Rando-Segura A, et al.
Neurology
. 2025 Jan;
104(3):e210281.
PMID: 39819099
Background And Objectives: Hepatitis B vaccination (HBV) requires 6 months to complete and is recommended for patients with multiple sclerosis (PWMS), particularly those who are candidates for anti-CD20 therapy. However,...
8.
Lageman S, Jolly A, Sahi N, Prados F, Kanber B, Eshaghi A, et al.
J Neurol
. 2025 Jan;
272(2):142.
PMID: 39812878
Cognitive impairment (CI) in multiple sclerosis (MS) is only partially explained by whole-brain volume measures, but independent component analysis (ICA) can extract regional patterns of damage in grey matter (GM)...
9.
Garbarino S, Tur C, Lorenzi M, Pardini M, Piana M, Uccelli A, et al.
Brain Commun
. 2025 Jan;
7(1):fcae434.
PMID: 39777254
This study applies the Gaussian process progression model, a Bayesian data-driven disease progression model, to analyse the evolution of primary progressive multiple sclerosis. Utilizing data from 1521 primary progressive multiple...
10.
Sahi N, Haider L, Chung K, Carrasco F, Kanber B, Samson R, et al.
Brain Commun
. 2024 Dec;
6(6):fcae443.
PMID: 39670111
The first genome-wide significant multiple sclerosis severity locus, rs10191329, has been pathologically linked to cortical lesion load and brain atrophy. However, observational cohorts such as MSBase have not replicated associations...